Progressive 13-cis-retinoic acid dosage in the treatment of oral leukoplakia
โ Scribed by Toma, S.; Mangiante, P.E.; Margarino, G.; Nicolo, G.; Palumbo, R.
- Book ID
- 123296949
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 378 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0964-1955
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Background. Surrogate endpoint biomarkers (SEBs) are detectable molecular, cellular, and tissue changes that take place during tumorigenesis and can be modulated by a chemoprevention agent. Method. To identify candidate SEBs for invasive squamous cell carcinoma of the upper aerodigestive tract (SCC
Recently, a new promising compound for the oral treatment of acne and other dermatologic disorders became available [7,8]. This substance, 13-cis retinoic acid (Ro 4-3780), is presently being evaluated in clinical trials. A group of 18 patients with severe acne, unresponsive to previous treatment, p